Followers | 1106 |
Posts | 279775 |
Boards Moderated | 10 |
Alias Born | 03/18/2011 |
Saturday, February 18, 2012 4:21:22 AM
~ $ATAI ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.
http://stockcharts.com/h-sc/ui?s=ATAI&p=D&b=3&g=0&id=p88783918276&a=237480049
http://stockcharts.com/h-sc/ui?s=ATAI&p=W&b=3&g=0&id=p54550695994
~ Google Finance: http://www.google.com/finance?q=ATAI
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=ATAI#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=ATAI+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=ATAI
Finviz: http://finviz.com/quote.ashx?t=ATAI
~ BusyStock: http://busystock.com/i.php?s=ATAI&v=2
<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=ATAI >>>>>>
http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916
*If the earnings date is in error please ignore error. I do my best.
My stuff http://investorshub.advfn.com/boards/read_msg.aspx?message_id=64797507
Never, invest with money you need to survive. Diversify, patience, set tight stops. $20 or less in commission fees is almost always cheaper than a 5-40%+ drop in share value.
Recent ATAI News
- atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression • GlobeNewswire Inc. • 04/24/2024 11:00:38 AM
- atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology • GlobeNewswire Inc. • 04/17/2024 11:00:01 AM
- atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights • GlobeNewswire Inc. • 03/28/2024 11:00:14 AM
- atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression • GlobeNewswire Inc. • 03/27/2024 11:00:33 AM
- atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01 • GlobeNewswire Inc. • 03/04/2024 01:00:18 PM
- atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/28/2024 10:00:06 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:29:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 10:05:28 PM
- atai Life Sciences Appoints Anne Johnson as Chief Financial Officer • GlobeNewswire Inc. • 02/06/2024 10:00:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 12:46:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 10:00:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:28:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:53:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:20:38 PM
- atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics • GlobeNewswire Inc. • 01/04/2024 12:00:00 PM
- atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA) • GlobeNewswire Inc. • 01/02/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2023 02:17:41 PM
- atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights • GlobeNewswire Inc. • 11/14/2023 12:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 08:15:43 PM
- ATAI LIFE SCIENCES ANNOUNCES FILING OF EARLY WARNING REPORT • PR Newswire (Canada) • 10/10/2023 12:00:00 PM
- atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit • GlobeNewswire Inc. • 10/06/2023 08:05:00 PM
- atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants • GlobeNewswire Inc. • 10/02/2023 08:13:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 08:38:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/14/2023 08:30:13 PM
- atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference • GlobeNewswire Inc. • 09/14/2023 12:02:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM